well then, I guess, ANPI should re-release the swedish study again, or have the Swedish study re-release its study again, whichever, if thats how Doctors or patients are chosing their stents.....unfckingbelievable!

also, nice to see there is some logic and reason behind why BSX doesn't just dump Taxus....apparently it is a good product and they would rather hedge their products by offering two stents rather then just rely on revenue stream from one of them.....